MedTrace Logo

Tricuspid Regurgitation Study

NCT01093001 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2016-11-03

No results posted yet for this study

Summary

The effect of cardiac pacing leads on tricuspid regurgitation is unclear. This study will determine whether using a smaller diameter leads and an alternate position in the ventricle, the proximal septum, will reduce tricuspid regurgitation than larger leads placed in the apex.

Conditions

  • Tricuspid Regurgitation
  • Right Ventricular Dysfunction
  • Left Ventricular Dysfunction

Interventions

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

OTHER

Echo

Two dimensional echocardiography will be performed to reassess Tricuspid Regurgitation.

Sponsors & Collaborators

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Yong-Mei Cha, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2015-09-30
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01093001 on ClinicalTrials.gov